GLAXOSMITHKLINE EXPORT LIMITED - Profile & Financials

Accounts Submitted 7 Jul 2025

Confirmation Statement Submitted 31 Jul 2025

Net assets £260.99M £11.55M 2024 year on year

Total assets £340.11M £6.99M 2024 year on year

Total Liabilities £79.12M £4.56M 2024 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

79 New Oxford Street London WC1A 1DG United Kingdom

Office (Ware)

45 Priory St, Ware SG12 0DE

Office (Brentford, Middlesex, United Kingdom)

980 Great West Road, TW8 9GS

Telephone

+302106882100

contract.manufacturing@gsk.com

Website

gsk.com

Credit Report

Discover GLAXOSMITHKLINE EXPORT LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£77.73M

Decreased by £3.65M (-4%)

Net Assets

£260.99M

Increased by £11.55M (+5%)

Total Liabilities

£79.12M

Decreased by £4.56M (-5%)

Turnover

£628.06M

Decreased by £13.67M (-2%)

Employees

Decreased by 193 (-85%)

Debt Ratio

23%

Decreased by 2 (-8%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

6 active 23 resigned

Show resigned officers

						Status
Aidan Lynch	Director	Irish	Ireland	62	26 Mar 2019	Active
Andrew James Collier	Director	British	England	59	1 Jan 2025	Active
Edinburgh Pharmaceutical Industries Limited	Corporate-secretary	United Kingdom	Unknown	—	4 Sept 2006	Active
Glaxo Group Limited	Corporate-director	United Kingdom	Unknown	—	8 Mar 2021	Active
Jerzy Radomir Toczyski	Director	Polish	Poland	61	2 Mar 2021	Active
Michael Sean Reilly	Director	British	United Kingdom	58	19 Apr 2023	Active

Shareholders

Shareholders (1)


Glaxo Group Limited	100.0%	100	Ordinary	5 Oct 2015

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Glaxo Group Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

GLAXO GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE FINANCE PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GSK PLC united kingdom

GLAXOSMITHKLINE EXPORT LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
12 Nov 2025	Officers	Appointment of Dr James Bringloe as director on 2025-11-01	View(2 pages)
12 Nov 2025	Officers	Termination of Michael Sean Reilly as director on 2025-11-01	View(1 page)
3 Sept 2025	Officers	Termination of Emma Hunter as director on 2025-09-01	View(1 page)
31 Jul 2025	Confirmation Statement	Confirmation statement made on 2025-07-31 with no updates	View(3 pages)
7 Jul 2025	Accounts	Annual accounts made up to 2024-12-31	View(29 pages)